Your browser doesn't support javascript.
Liver transplantation in a patient after COVID-19 - Rapid loss of antibodies and prolonged viral RNA shedding.
Niess, Hanno; Börner, Nikolaus; Muenchhoff, Maximilian; Khatamzas, Elham; Stangl, Manfred; Graf, Alex; Girl, Philipp; Georgi, Enrico; Koliogiannis, Dionysios; Denk, Gerald; Irlbeck, Michael; Werner, Jens; Guba, Markus.
  • Niess H; Department of General, Visceral, and Transplant Surgery, Ludwig-Maximilians-University, Munich, Germany.
  • Börner N; Department of General, Visceral, and Transplant Surgery, Ludwig-Maximilians-University, Munich, Germany.
  • Muenchhoff M; Virology, Max von Pettenkofer Institute, Ludwig-Maximilian-University, Munich, Germany.
  • Khatamzas E; German Center for Infection Research (DZIF, Partner Site Munich, Munich, Germany.
  • Stangl M; Department of Internal Medicine III, Ludwig-Maximilians-University, Munich, Germany.
  • Graf A; Department of General, Visceral, and Transplant Surgery, Ludwig-Maximilians-University, Munich, Germany.
  • Girl P; Laboratory for Functional Genome Analysis, Gene-Center, Ludwig-Maximilians-University, Munich, Germany.
  • Georgi E; Bundeswehr Institute of Microbiology, Munich, Germany.
  • Koliogiannis D; Bundeswehr Institute of Microbiology, Munich, Germany.
  • Denk G; Department of General, Visceral, and Transplant Surgery, Ludwig-Maximilians-University, Munich, Germany.
  • Irlbeck M; Department of Internal Medicine II, Ludwig-Maximilians-University, Munich, Germany.
  • Werner J; Department of Anesthesiology, Ludwig-Maximilians-University, Munich, Germany.
  • Guba M; Department of General, Visceral, and Transplant Surgery, Ludwig-Maximilians-University, Munich, Germany.
Am J Transplant ; 21(4): 1629-1632, 2021 04.
Article in English | MEDLINE | ID: covidwho-852163
ABSTRACT
To date, little is known about the duration and effectiveness of immunity as well as possible adverse late effects after an infection with SARS-CoV-2. Thus it is unclear, when and if liver transplantation can be safely offered to patients who suffered from COVID-19. Here, we report on a successful liver transplantation shortly after convalescence from COVID-19 with subsequent partial seroreversion as well as recurrence and prolonged shedding of viral RNA.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Liver Transplantation / Virus Shedding / End Stage Liver Disease / COVID-19 / Antibodies, Viral Type of study: Case report / Prognostic study Topics: Long Covid Limits: Humans / Male / Middle aged Language: English Journal: Am J Transplant Journal subject: Transplantation Year: 2021 Document Type: Article Affiliation country: Ajt.16349

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Liver Transplantation / Virus Shedding / End Stage Liver Disease / COVID-19 / Antibodies, Viral Type of study: Case report / Prognostic study Topics: Long Covid Limits: Humans / Male / Middle aged Language: English Journal: Am J Transplant Journal subject: Transplantation Year: 2021 Document Type: Article Affiliation country: Ajt.16349